Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma
Claudia A. Dumitru(Otto-von-Guericke-Universität Magdeburg), I. Erol Sandalcioglu(Otto-von-Guericke-Universität Magdeburg)
Cited by 11
Related Papers
Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma
|Frontiers in Immunology|2013|30
PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
|International Journal of Molecular Sciences|2022|18